The Company (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		12 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Accumulated deficit				$ 503,809	$ 470,853
Net cash used in operating activities				19,701	$ 36,869
Cash, cash equivalents, and short-term investments				66,500
Minimum annual net revenue				45,000
Minimum cash and cash equivalents required after completion of IPO				5,000
Forecast
Subsidiary, Sale of Stock [Line Items]
Minimum annual net revenue			$ 70,000
Minimum cash and cash equivalents required after completion of IPO			$ 5,000
At-the-Market Equity Offering
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of preferred stock, preference stock, and warrants		$ 150,000
Proceeds from issuance or sale by company of common stock		$ 50,000
Percentage of shares of common stock sold under sales agreement		3.00%
Number of shares issued in transaction (in shares)	933,500
Issuance of common stock		$ 8,100
Sale of weighted average price (in dollars per share)		$ 8.71
Aggregate net proceeds		$ 7,600
Amount remaining under ATM program				$ 41,900